Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Filings indexed 861 across all filing types
Latest filing 2026-02-20 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2026-02-20 English
General Updates
Environmental & Social Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding an ESG rating assigned by an external agency. It references SEBI regulations and provides details about the ESG scores for the company. The document does not contain financial statements, audit information, or detailed management discussion. It is an announcement of ESG-related information, specifically the ESG rating assigned by a third party, which aligns with Environmental & Social Information filings. The document length is short and it is not a report itself but an official disclosure of ESG rating information under regulatory requirements.
2026-02-19 English
Monitoring Agency Report
Regulatory Filings
2026-02-10 English
Press Release
Regulatory Filings
2026-02-10 English
Outcome of Board Meeting
Regulatory Filings
2026-02-10 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.